Skip to main content

> GUIDE // FOUNDATIONS

FDA Cybersecurity in Medical Devices: Quality System Considerations and Premarket Submissions

Threat modeling, Software Bill of Materials (SBOM), vulnerability disclosure, and post-market patching.

Executive Overview

Under Section 524B of the FD&C Act, medical device manufacturers must design, develop, and maintain cyber-secure devices throughout their entire lifecycle to receive FDA 510(k), De Novo, or PMA clearance.

1. Core FDA Statutory Requirements for Cyber Devices

The FDA statutory cybersecurity mandate establishes four non-negotiable pillars:

  • Secure Product Design & Threat Modeling: Architectural threat models demonstrating risk reduction to an acceptable residual level.
  • Software Bill of Materials (SBOM): Machine-readable inventory (CycloneDX or SPDX) listing all proprietary, open-source, and third-party software components.
  • Vulnerability Management & Coordinated Disclosure: Documented processes to monitor, triage, and patch vulnerabilities within strict regulatory timelines.
  • Patching & Update Mechanism: Cryptographically verified firmware and software update delivery without requiring device recall.

Frequently Asked Questions

What happens if an FDA submission lacks a machine-readable SBOM?

Under FDA eSTAR and Refuse-to-Accept (RTA) policy, submissions without a valid machine-readable SBOM will be immediately rejected without substantive scientific review.

AI Summary

Under Section 524B of the FD&C Act, medical device manufacturers must design, develop, and maintain cyber-secure devices throughout their entire lifecycle to receive FDA 510(k), De Novo, or PMA clearance.